Charcot's foot: Newest findings on its pathophysiology, diagnosis and treatment
- 30 September 2010
- journal article
- review article
- Published by Elsevier BV in Diabetes & Metabolism
- Vol. 36 (4), 251-255
- https://doi.org/10.1016/j.diabet.2010.04.002
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Association Between Osteoprotegerin G1181C and T245G Polymorphisms and Diabetic Charcot NeuroarthropathyDiabetes Care, 2009
- Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trialBone, 2008
- Increased osteoclastic activity in acute Charcot’s osteoarthopathy: the role of receptor activator of nuclear factor-kappaB ligandDiabetologia, 2008
- Is There a Systemic Inflammatory Response in the Acute Charcot Foot?Diabetes Care, 2007
- Evaluation of the Diabetic Charcot Foot by MR Imaging or Plain Radiography - an Observational StudyExperimental and Clinical Endocrinology & Diabetes, 2006
- Intranasal Calcitonin in the Treatment of Acute Charcot NeuroosteoarthropathyDiabetes Care, 2006
- Osteoclast differentiation and activationNature, 2003
- Treatment of Diabetic Foot Ulcers and Charcot Neuroarthropathy Using the Patellar Tendon-Bearing BraceFoot & Ankle International, 1997
- Art. VI. Further Cases and Observations relative to Rheumatism.The American Journal of the Medical Sciences, 1833
- Art. IV. Ona New Practice in Acute and Chronic Rheumatism.The American Journal of the Medical Sciences, 1831